Macquarie Capital Securities

Rediff.com » News » Macquarie Capital Securities

News for Macquarie Capital Securities

Business

Aurobindo Pharma: Strong prospects offset by valuation concerns

Since the start of this financial year (FY24), the stock of Aurobindo Pharma has been one of the top pharma gainers, enhancing investor wealth by over 68 per cent, with a third of those gains......

HDFC Bank's ADR premium plunges below 5%, lowest since June last year

The country’s most valuable lender HDFC Bank can perhaps no longer claim to be a favourite of foreign portfolio investors (FPIs). Photograph: Shailesh Andrade/Reuters Two data indicators,......

More downside seen in Infosys earnings estimate; stock to derate: Analysts

Infosys was the only large-cap IT player to report sequential constant currency (cc) revenue growth for the June quarter (1 per cent ), which was ahead of analyst expectations, but the......

HDFC - HDFC Bank merger: What's in store for the shareholders?

HDFC and HDFC Bank’s merger – touted as India's biggest-ever corporate merger – pumped up shares of the two entities on the bourses. Photograph: Danish Siddiqui/Reuters Shares of......

What acquisition of Citi's retail biz means for Axis Bank

The quality of customers it acquires holds the key to success but the benefits of the buyout could kick in only from FY25. Manojit Saha and Subrata Panda report. Photograph: Arko Datta/Reuters......

Rediff News

Macquarie Capital Securities

News for Macquarie Capital Securities

Aurobindo Pharma: Strong prospects offset by valuation concerns

HDFC Bank's ADR premium plunges below 5%, lowest since June last year

More downside seen in Infosys earnings estimate; stock to derate: Analysts

HDFC - HDFC Bank merger: What's in store for the shareholders?

What acquisition of Citi's retail biz means for Axis Bank

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS